OBJECTIVES: Mesh removal is an option for the management of complications arising from synthetic mesh placement for stress urinary incontinence (SUI). Definitions of "complete" versus "partial" removal of midurethral sling mesh vary. Using an objective measurement to define these terms could help physicians to better study mesh removal. To date, it has not yet been described how much mesh by length is explanted during complete retropubic (RP) and transobturator (TO) sling removals. The objective of this study was to determine the median length of midurethral slings, both RP and TO, that is explanted during complete removal of sling mesh. MATERIALS AND METHODS: Following IRB approval, a retrospective chart review of a referral urogynecology practice was performed from January 2015 to December 2015 by CPT code 57287 (sling revision/removal). Complete removal of a RP sling was defined as excision of the vaginal portion as well as the retropubic arms coursing through the retropubic space, rectus abdominus, and subcutaneous tissues. Complete removal of a TO sling was defined as excision of the vaginal portion as well as the lateral arms coursing through the obturator/adductor muscles. Inclusion criteria included patients who had a prior RP or TO sling and underwent a complete sling removal with no prior history of sling excision. Single-incision slings and those with incomplete or unclear pathology reports were excluded. Mesh length in centimeters (cm) was collected and analyzed descriptively. A subanalysis was also performed comparing patient body mass index (BMI) by World Health Organization classification to explant length using a Mann-Whitney U test. RESULTS: Of the 114 patients undergoing complete sling removal, there were 55 sling explants included in the analysis. The median length of the complete RP mesh explants (n ¼ 23) was 25.5 cm (15.4-35.2 cm). The median length of the complete TO mesh explants (n ¼ 32) was 18.4 cm (12.8-29.2 cm). Patients with a normal BMI had a significantly smaller RP explant length (median ¼ 23.3 cm) than obese patients (median ¼ 29.0 cm), U ¼ 13, p ¼ 0.049. However, TO explant length was similar in patients with a normal BMI and those classified as obese (median: 18.2 cm vs 18.8 cm, respectively), U ¼ 26, p ¼ 0.98. CONCLUSION: This is the first series to describe the length of mesh explant based upon pathology after complete sling removal. Our study identified a wide range of mesh lengths in both RP and TO explantation. The lack of uniformity of sling length between patients complicates the preoperative prediction of an individual patient's suspected mesh length. Furthermore, for patients presenting with a history of sling revision, simply knowing the length of mesh previously excised does not provide the surgeon with enough information to estimate the amount of mesh remaining in vivo. Therefore, surgeons need to obtain both pathologic reports and detailed operative report description of previous mesh excisions to make an accurate prediction of the amount of mesh remaining in the patient. While our findings indicate a relationship between BMI and length of RP sling explanted, further study into other specific patient characteristics, which could affect mesh length, may be helpful.
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63 Using the questionnaire for urinary incontinence diagnosis as screening tool in low resource settings 
OBJECTIVES:
The Questionnaire for Urinary Incontinence Diagnosis (QUID) is a validated and reliable 6-item urinary incontinence (UI) symptom questionnaire used to distinguish patients with urge (UUI), stress (SUI) and mixed incontinence (MUI). We aim to evaluate the utility of QUID as a tool for untrained community health workers (CHW) in low resource settings. We aim to determine whether the QUID can help identify patients with UI who will benefit from physician evaluation. outreaches to 160 rural communities with limited access to care. At an annual educational symposium, the CHWs or "cooperadoras" were taught to administer the QUID to women complaining of UI. These women were then referred to the main clinical evaluation center for a UI assessment. A clinician asked these women 3 stress-related and 5 urge-related questions. The diagnosis after administration of the QUID by the CHWs was correlated with physician diagnosis after asking these 8 clinician questions. Clinicians then performed a thorough physical examination, urine dipstick, post-void residual, cough stress test, and simple cystometrics on patients with a negative cough stress test. The QUID diagnosis was correlated to physician diagnosis after both clinician questions and physical examination. RESULTS: The CHWs administered the QUID to 101 women who had complaints of UI with following diagnoses: MUI 73.2%, UUI 6%, SUI 0%, and no incontinence 20.8%. After initial clinician evaluation and the 8 clinician questions, diagnoses were as follows: MUI 34.65%, UUI 4%, SUI 34.65%, and 26.7% with no incontinence. The correlation coefficient between the QUID and the clinician questions was 0.78. After thorough physical examination as above, final diagnoses were as follows: MUI 15.8%, UUI 14.9%, SUI 26.7%, 41.6% with no incontinence, and 1% with a urinary tract infection. The correlation coefficient between the QUID and the final diagnosis was 0.185 (Table 1) . CONCLUSION: CHW diagnosis after QUID administration correlated well with clinician diagnosis after 8 clinician questions. This suggests that the QUID can be an excellent screening tool for CHWs in rural communities for triage, just as the 8 clinician questions are used to triage patients by physicians prior to physical examination and evaluation. It should be noted that the QUID does not diagnose SUI as frequently as physicians do with clinician questions on initial evaluation. The QUID diagnosis poorly correlated with physician final diagnosis. This is likely because additional tests, such as urine dipstick, post-void residual, cough stress test, and simple cystometrics supply more information to differentiate accurately between SUI and UUI, which were diagnosed much more frequently from the physician diagnosis than the QUID diagnosis. However, the QUID was able to identify high-risk women who should receive an evaluation by a physician for UI.
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64 Pelvic floor disorders and psychiatric diagnoses: Are they related?
A. Leader-Cramer, B. Dave, K. Kenton, C. Lewicky-Gaupp
Obstetrics and Gynecology, Division of Female Pelvic Medicine and Reconstructive Surgery, Northwestern University, Chicago, IL OBJECTIVES: To identify the prevalence of psychiatric diagnoses in a Female Pelvic Medicine and Reconstructive Surgery (FPMRS) clinic population and to determine if associations exist between these diagnoses and pelvic floor disorders (PFDs). MATERIALS AND METHODS: We retrospectively reviewed de-identified medical records for all new patients who presented to the FPMRS clinic from 2007-2013. Urogynecologic and psychiatric diagnoses were identified by ICD-9 codes. Statistical analysis of patients with various PFDs was performed comparing those patients with and without psychiatric diagnoses. Chi-square was used for categorical data and Student's t-test or Mann-Whitney U test were utilized for continuous data. Backwards multivariate logistic regression was also performed to identify those variables related to PFDs significantly correlated with having a psychiatric diagnosis. RESULTS: A total of 6,461 women were seen in the FPMRS clinic during this time. Patients had a mean age of 60.8 AE 16.3 years and most were white (58%). Half (50%) carried at least one comorbid psychiatric diagnosis. The number of psychiatric diagnoses in those affected ranged from 1-11 with a median of 3. The majority (75%) of patients had more than one PFD diagnosed with a median of 3 (range ¼ 1-14).
High-tone pelvic floor/painful bladder syndrome (PBS), overactive bladder (OAB), fecal incontinence (FI), and neurogenic bladder were each associated with having a psychiatric diagnosis on multivariate logistic regression. Each PFD had a different constellation of associated comorbid psychiatric disorders, however, anxiety disorders were linked to every PFD correlated with having a psychiatric diagnosis (Table) . PFDs that were not associated with psychiatric comorbidities were stress urinary incontinence, acute/ recurrent urinary tract infection, nocturia, mesh complications, vulvovaginal atrophy, care for obstetric anal sphincter injury after delivery, and genitourinary or rectovaginal fistula. Patients were more likely to receive a referral to pelvic floor physical therapy for treatment of PFD if they were white and younger, had an anxiety disorder, psychosis, or sexual disorder. They were less likely to be referred if they were Black/African American, had post-traumatic stress disorder or dementia. White or Hispanic race were correlated with undergoing a urogynecologic surgery, while patients of Black/ African American race were less likely to undergo surgery for their PFD. Patients with comorbid anxiety or dementia were also less likely to have surgery. CONCLUSION: Comorbid psychiatric diagnoses are found in half of the FPMRS patient population and often correlate with common PFDs. Anxiety disorders correlated highly with all PFDs associated with having a psychiatric disorder. As psychiatric diagnoses may have an effect on clinical practice patterns, clinicians should take this into account when counseling and treating patients with PFDs.
